PTGX Operating Cash Flow (Statement)
Protagonist Therapeutics Inc · Operating Cash Flow (Statement)
PTGX Operating Cash Flow (Statement)
Latest reported$131.20Mperiod ending
PTGX Cash from Operations (-$7.74M → $131.20M)
Annual operating cash flow (statement)
High-resolution chart · PNG
PTGX operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 57,671,000 | |
| 184,152,000 | |
| -70,236,000 | |
| -108,137,000 | |
| -107,865,000 | |
| -72,484,000 | |
| -41,527,000 | |
| -49,947,000 | |
| 3,872,000 | |
| -29,972,000 | |
| -14,385,000 | |
| -7,743,000 |